Spironolactone
Aldactone
Aldosterone Antagonist
NADAC/unit
$0.0456
No Shortage
Tier 1: 263.2%
12 Manufacturers
32 ANDAs
Spironolactone is an aldosterone antagonist indicated for: The treatment of NYHA Class III-IV heart failure and reduced ejection fraction to increase survival, manage edema, and to reduce the need ....
vs. brand Aldactone: Generic saves up to 100% per unit
Active Shortages
2025-12-10 Discontinuation of the manufacture of the drug., Pfizer Inc.
2025-12-10 Discontinuation of the manufacture of the drug., Pfizer Inc.
Market Intelligence
2025-08-13 Class II Recall: SUN PHARMACEUTICAL INDUSTRIES INC
Generic Manufacturers
ACCORD HEALTHCARE INCAMNEAL PHARMACEUTICALS LLCAMNEAL PHARMACEUTICALS OF NEW YORK LLCANNORA PHARMA PRIVATE LTDAUROBINDO PHARMA LTDCMP DEVELOPMENT LLCGRAVITI PHARMACEUTICALS PRIVATE LTDHETERO LABS LTD UNIT IIIJUBILANT GENERICS LTDMYLAN PHARMACEUTICALS INCOXFORD PHARMACEUTICALS LLCPFIZER INCSUN PHARMACEUTICAL INDUSTRIES INCZYDUS PHARMACEUTICALS USA INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.